B. Jelli, O. Taton, N. D’Haene, M. Remmelink, and Z. Mekinda, “ Complete Response to Afatinib of an EGFR Exon 18 delE709_T710insD-Mutated Stage IV Lung Adenocarcinoma”, EJCRIM, vol. 8, no. 8, Aug. 2021.